The ability of the CD163+ monocytes to clear and regulate extracellular ATP may be potentially diminished in individuals with diabetes complications due to the decreased expression of the ectonucleotides CD39 and CD73 (Figure 6). This evidence concerns the gene CD163 and diabetes mellitus.